Harvard Apparatus Regenerative Technology, Inc. (HRGN)
About Harvard Apparatus Regenerative Technology, Inc.
HARVARD APPRATS REG TCH
This profile is unclaimed. An authorized representative can claim it to add details and earn the Verified badge.
Financial summary
- Revenue FY2025
- $704.0K
- Net income
- -$6.9M
- Total assets
- $2.7M
Source: SEC EDGAR · updated Jun 7, 2026
15-minute delayed · data by Polygon.io
Past year · hover for prices
52-week range
- Open
- —
- Day range
- –
- Prev close
- —
- Volume
- —
Harvard Apparatus Regenerative Technology, Inc. (HRGN) Stock Price
- Reported a net loss of $6.9M in FY2025.
- Trading 53% below its 52-week high.
Automatically generated from public filings and market data. Informational only — not investment advice or a recommendation to buy or sell any security.
No reviews yet. Be the first to review Harvard Apparatus Regenerative Technology, Inc..
Write a review
News about Harvard Apparatus Regenerative Technology, Inc.
News & sentiment via Polygon.io
Harvard Apparatus Regenerative Technology, Inc.: frequently asked questions
Is Harvard Apparatus Regenerative Technology, Inc. an American company?
Harvard Apparatus Regenerative Technology, Inc. is a US-based company headquartered in Holliston, Massachusetts, listed in the americancompanies.com directory of American companies. Its American-origin credentials have not yet been independently verified.
Where is Harvard Apparatus Regenerative Technology, Inc. headquartered?
Harvard Apparatus Regenerative Technology, Inc. is headquartered in Holliston, Massachusetts, United States.
Is Harvard Apparatus Regenerative Technology, Inc. publicly traded?
Yes — Harvard Apparatus Regenerative Technology, Inc. is a publicly traded company. Its stock trades under the ticker symbol HRGN on the OTC.
What does Harvard Apparatus Regenerative Technology, Inc. do?
Harvard Apparatus Regenerative Technology, Inc. is an American Medical Devices company in the Health & Beauty sector.
